205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.04%
Negative revenue growth while AMD stands at 6.34%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.64%
Negative gross profit growth while AMD is at 5.72%. Joel Greenblatt would examine cost competitiveness or demand decline.
-18.51%
Negative EBIT growth while AMD is at 38.16%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-18.97%
Negative operating income growth while AMD is at 52.68%. Joel Greenblatt would press for urgent turnaround measures.
-19.78%
Negative net income growth while AMD stands at 123.08%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-20.21%
Negative EPS growth while AMD is at 127.78%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-19.46%
Negative diluted EPS growth while AMD is at 127.78%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
4.88%
Dividend growth of 4.88% while AMD is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-0.67%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
75.57%
Positive FCF growth while AMD is negative. John Neff would see a strong competitive edge in net cash generation.
61.04%
10Y revenue/share CAGR at 50-75% of AMD's 82.31%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
15.12%
5Y revenue/share CAGR under 50% of AMD's 169.52%. Michael Burry would suspect a significant competitive gap or product weakness.
1.24%
3Y revenue/share CAGR under 50% of AMD's 44.49%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
91.92%
10Y OCF/share CAGR under 50% of AMD's 752.13%. Michael Burry would worry about a persistent underperformance in cash creation.
-5.86%
Negative 5Y OCF/share CAGR while AMD is at 237.49%. Joel Greenblatt would question the firm’s operational model or cost structure.
-8.36%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
220.89%
Net income/share CAGR at 75-90% of AMD's 252.00%. Bill Ackman would press for strategic moves to boost long-term earnings.
16.14%
Below 50% of AMD's 988.35%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-17.80%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
87.00%
Below 50% of AMD's 4725.61%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
97.18%
Below 50% of AMD's 2637.43%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
86.15%
Below 50% of AMD's 627.68%. Michael Burry suspects a serious short-term disadvantage in building book value.
333.29%
Dividend/share CAGR of 333.29% while AMD is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
68.41%
Dividend/share CAGR of 68.41% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
27.57%
3Y dividend/share CAGR of 27.57% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-9.56%
Firm’s AR is declining while AMD shows 6.53%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.33%
We show growth while AMD is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.24%
Asset growth above 1.5x AMD's 0.38%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.60%
Under 50% of AMD's 4.52%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
5.05%
Debt growth far above AMD's 4.93%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-2.34%
Our R&D shrinks while AMD invests at 0.27%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.10%
We cut SG&A while AMD invests at 11.81%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.